Category:

Eco/Invest/Demography

Insurers drop appeal against UK COVID-19 payout ruling on three policies

appeals linked to the Resilience, Eaton Gate Retail, and Eaton Gate Pubs & Restaurants policies have now been dropped, legal documents show, raising hopes that hundreds of vulnerable businesses could see their claims processed without further delay.

A spokesman for RSA, one of the largest of the six insurers, said it would work with broker Marsh to make interim payments where appropriate.

Businesses across the world have been locked in disputes with insurance companies over pandemic-related payouts.

read more

COVID-19: India records 55,839 new infections, 702 deaths

The active cases of coronavirus infection remained below eight lakh for the sixth consecutive day

There are 7,15,812 active cases of coronavirus infection in the country which accounts for 9.29 per cent of the total caseload, the data stated
According to the Indian Council of Medical Research (ICMR), a cumulative total of 9,86,70,363 samples have been tested up to October 21, of which 14,69,984 were tested on Wednesday.

read more

Number of South Koreans dying after flu shot rises, prompts vaccine worries

South Korea’s vaccines come from a variety of sources. Manufacturers include local drug makers GC Pharma, SK Bioscience and Ilyang Pharmaceutical Co, along with France’s Sanofi and Britain’s Glaxosmithkline. Distributors include LG Chem Ltd and Boryung Biopharma Co. Ltd., a unit of Boryung Pharm Co. Ltd..GC Pharma, LG Chem, SK Bioscience and Boryung declined to comment. Ilyang Pharmaceutical, Sanofi and GSK could not immediately be reached for comment.

read more

India has set aside $7 billion to vaccinate the world’s second Biggest Population

Prime Minister Narendra Modi’s administration estimates an all-in cost of about $6-$7 per person in the nation of 1.3 billion, the people said, asking not to be identified as the details are private. The money provisioned so far is for the current financial year ending March 31 and there will be no shortage of further funds for this purpose, they added.A Finance Ministry spokesman couldn’t immediately be reached when tried on his mobile.

read more

Tesla’s release of new ‘self-driving’ software closely watched by U.S. regulato

“NHTSA has been briefed on Tesla’s new feature, which represents an expansion of its existing driver assistance system. The agency will monitor the new technology closely and will not hesitate to take action to protect (the) public against unreasonable risks to safety,” the National Highway Traffic Safety Administration said in a statement.

read more

Further rate hardening expected,cyber insurance market to surpass $ 7bn in 2020:Munich Re

Recent experiences following the lockdown of public life and the business world in many countries have been a wake-up call regarding the staggering potential for systemic risks to result in losses that subsequently trigger many different repercussions. Yet it is by definition impossible to insure risks that lead to losses everywhere at the same time, thus violating the fundamental criterion of insurability, said Munich Re. 

Interest rates have dropped to record lows once again in 2020. Against the backdrop of the coronavirus crisis, it is increasingly likely that the current interest-rate environment will continue to affect low-risk investments for the foreseeable future. These circumstances mean that sustained profits, in long-tail business and elsewhere, will only be possible if prices match the assumed risks, explained Munich Re..

read more

IRDAI issues stringent advertisement norms for insurance industry  

The IRDAI has also asked the insurers to issue a statutory warning, saying “No person shall allow or offer to allow, either directly or indirectly, as an inducement to any person to take out or renew or continue an insurance in respect of any kind of risk relating to lives or property in India, any rebate of the whole or part of the commission payable or any rebate of the premium shown on the policy, nor shall any person taking out or renewing or continuing a policy accept any rebate, except such rebate as may be allowed in accordance with the published prospectus or tables of the insurer.” 

read more

AstraZeneca COVID-19 vaccine trial volunteer has died, Brazil health authority says

The regulator said testing of the vaccine would continue after the volunteer’s death. It provided no further details, citing medical confidentiality of those involved in trials.

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian but did not say where the person lived.

read more